Coming soon? Medline eyes $5B IPO, according to reports
By HME News Staff
Updated 9:12 AM CDT, Tue September 30, 2025
NORTHFIELD, Ill. - Medline may soon be ready to pull the trigger on an initial public offering (IPO), according to Bloomberg and other news outlets. The company may file for an IPO as early as late October in a bid to raise $5 billion, potentially valuing it at $50 billion, they report. Earlier this year, Medline confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed IPO of its common stock. In 2021, the company announced it had received outside investment from private equity firms Blackstone, Carlyle, and Hellman & Friedman in a deal reportedly worth more than $30 billion. Since then, the company has made multiple moves to strengthen its role as a strategic partner, including joining forces with Microsoft to address supply chain complexity. In 2023, Medline promoted Jim Boyle to serve as CEO, and Jim Pigott as president & COO, culminating a five-year succession planning process.
Comments